Assessment of general cognitive MMSE Moca tics

To assess MCI in patients with CKD not yet on dialysis. The Montreal Cognitive Assessment ( MoCA) has been indicated for MCI screening in CKD.

Individuals with chronic kidney disease (CKD) are at higher risk of developing cognitive impairment (CI), initially mild (MCI), potentially identifiable, but still poorly diagnosed and treated. Paraizo, Marilise de Andrade Almeida, Ana Laura Maciel Pires, Leopoldo AntÃ´nio Abrita, Renata Silva Almeida Crivellari, Mary Hellen Teixeira Pereira, Beatriz Dos Santos Fernandes, NatÃ¡lia Maria da Silva Bastos, Marcus Gomes Montreal Cognitive Assessment ( MoCA) screening mild cognitive impairment in patients with chronic kidney disease (CKD) pre-dialysis. The MoCA is a sensitive and accurate instrument for screening the patients with bv-FTD and represents a better option than the MMSE. With a cutoff below 17 points, the MoCA results for sensitivity, specificity, positive predictive value, negative predictive value, and classification accuracy were significantly superior to those of the MMSE. The diagnostic accuracy of MoCA for bv-FTD was extremely high (area under the curve AUC = 0.934, 95% confidence interval = 0.866-.974 AUC = 0.772, 95% CI = 0.677-0.850). Compared with the MMSE, the MoCA demonstrated consistently superior psychometric properties and discriminant capacity, providing comprehensive information about the patients' cognitive profiles. Three matched subgroups of participants were considered: bv-FTD (n = 50), Alzheimer disease (n = 50), and a control group of healthy adults (n = 50). The aim of the present study was to validate the MoCA as a cognitive screening test for behavioral-variant frontotemporal dementia (bv-FTD) by examining its psychometric properties and diagnostic accuracy. The Montreal Cognitive Assessment ( MoCA) is a brief instrument developed for the screening of milder forms of cognitive impairment, having surpassed the well-known limitations of the Mini-Mental State Examination (MMSE). Montreal Cognitive Assessment ( MoCA): validation study for frontotemporal dementia.įreitas, Sandra SimÃµes, MÃ¡rio R Alves, Lara Duro, Diana Santana, Isabel

We conclude that the MoCA, although not necessarily superior to the MMSE, is a useful instrument for assessing cognitive performance over a broad level of functioning in HD. Even mild HD subjects showed significant differences with regard to total score and several cognitive domains on both instruments. For the total HD sample, and for the moderate and severe patients, significant differences between both MoCA and MMSE total scores and almost all cognitive-specific domains emerged. We compared MoCA and MMSE total scores and the number of correct answers in 5 cognitive-specific domains in 104 manifest HD patients and 100 matched controls. This study examined its usefulness for assessing cognitive performance in mild, moderate, and severe Huntington's disease (HD), compared with the use of the Mini-Mental State Examination (MMSE). The Montreal Cognitive Assessment ( MoCA) is a brief screening instrument for dementia that is sensitive to executive dysfunction. Gluhm, Shea Goldstein, Jody Brown, Daniel Van Liew, Charles Gilbert, Paul E Corey-Bloom, Jody Usefulness of the Montreal Cognitive Assessment ( MoCA) in Huntington's disease.

Assessment of general cognitive MMSE Moca tics